Increase in Prevalence of Diabetes Anticipated to Drive Global Diabetic Neuropathy Market over the Forecast Period: Ken Research REQUEST FOR SAMPLE REPORT Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit Buy Now Diabetic neuropathy is a nerve destructive disorder associated with diabetes mellitus. It is defined by the presence of proteinuria. It is a form of chronic kidney disease which occurs when the kidney is exposed to persistent hyperglycemia. It is damage caused to the nerve due to diabetes that often leads to pain & numbness in feet or lower legs. The pain can be experienced in other parts of the body for instance wrist, hips, and back depending upon the effect of neuropathy. It affects about 20-40% of patients with diabetes mellitus. According to the study, “Global diabetic neuropathy Market Size study, by Disorder Type (autonomic Neuropathy, peripheral neuropathy, proximal neuropathy, and focal Neuropathy) Treatment (drugs, physiotherapy, radiotherapy, and others) Distribution Channel (clinics, hospitals and pharmacy) and Regional Forecasts 2018-2025” the key companies operating in the global diabetic neuropathy market areMEDA Pharma GmbH & Co. KG, Cephalon, Inc., Pfizer Inc., Eli Lilly, and Company, Janssen Pharmaceuticals, Inc., Abbott Laboratories, Daiichi Sankyo Company Limited, ACTAVIS, NeuroMetrix, Inc., Novartis AG, Johnson & Johnson Services, Inc., Lupin Limited, GlaxoSmithKline. The key vendors are progressively focusing on the development of disease-modifying drugs to treat diabetic neuropathy owing to its growing prevalence. Vendors are also focusing on the introduction of injectable gene therapy aimed at enduring pain relief associated with diabetic peripheral neuropathy. Based on disorder type, the global diabetic neuropathy market is segmented into autonomic neuropathy, peripheral neuropathy, focal neuropathy, and proximal neuropathy. The autonomic neuropathy segment affects body function such as blood pressure, heart rate, digestion, and perspiration. Peripheral neuropathy affects the legs and feet. Focal neuropathy affects the nerves, foot, wrist, and thigh. Proximal neuropathy affects hips, thighs, legs, and buttocks. Based on treatment type, the market is segmented into physiotherapy, drugs, radiotherapy, and others. Drugs segment is further sub-segmented into antidepressant (Selective Nor-epinephrine Reuptake Inhibitors (SNRIs), Tricyclic Anti-depressants (TCAs), Selective Serotonin Reuptake Inhibitors (SSRIs)), analgesics (opioids (morphine and others), topical (capsaicin and others) and non-steroidal anti-inflammatory drugs (NSAIDs)) and anticonvulsants (topiramate, pregabalin, gabapentin, and others). Additionally, radiotherapy is further sub-segmented into TENS and others. In addition, based on the distribution channel, the market is segmented into retail pharmacies, hospitals, online pharmacy and clinics. The global diabetic neuropathy market is driven by a rise in the prevalence of diabetes, followed by a change in lifestyle habits, rise in urbanization, growth in awareness regarding diagnosis & treatment of diabetes, approval of new drugs, rise in demand for the development of better neuropathy drugs, the presence of a strong drug pipeline and change in genetic composition. However, the high cost of diabetic drugs, lack of absolute treatment, side effects with the diabetic neuropathy treatment and lack of awareness among the patients may impact the market. Moreover, growth in the prevalence of obesity & numerous cardiovascular diseases is a key opportunity for the market. Furthermore, favorable reimbursement scenario and new therapeutics for the treatment of neuropathy is a major trend for the market. Based on geography, the North-American region holds the leading position in diabetic neuropathy market owing to improvement in healthcare infrastructure, an increase in the prevalence of diabetes and a rise in research and development (R&D) activities for drug discovery in the region. Whereas, the Asian-Pacific and European regions are expected to witness higher growth rate due to the increase in aging population and improvement in healthcare services in rural areas over the forecast period. In upcoming years, it is estimated that the future of the market will be bright on account of growth in the development of novel biologics to treat diabetic neuropathy and the launch of a new medication to manage the symptoms of chronic diabetic neuropathy during the forecast period. It is expected that the market will be reached at the US $5.8 billion by 2025. To Know More, Click On The Link Below:- Global Diabetic Neuropathy Market Analysis Related Reports:- Global Diabetic Neuropathy Market Size study, by Types of Disorder (Peripheral Neuropathy, Autonomic Neuropathy, Proximal Neuropathy, Focal Neuropathy), and by Regional Forecasts 2018-2025 PharmaPoint: Painful Diabetic Neuropathy-Global Drug Forecast and Market Analysis to 2026 Contact Us:- Ken Research Ankur Gupta, Head Marketing & Communications Ankur@kenresearch.com +91-9015378249 Tags: Abbott Diabetic Neuropathy Market Sales Forecast, ACTAVIS Diabetic Neuropathy Market Growth Rate, Asia Pacific Diabetic Neuropathy Market, Canada Diabetic Neuropathy Market, Cephalon Diabetic Neuropathy Market Size, Eli Lilly Diabetic Neuropathy Market Share, Europe Diabetic Neuropathy Market, Germany Diabetic Neuropathy Market, GlaxoSmithKline Diabetic Neuropathy Market, Global Diabetic Neuropathy Industry Research Report, Global Diabetic Neuropathy Market Analysis, Global Diabetic Neuropathy Market Forecast, Global Diabetic Neuropathy Market Future Outlook, Global Diabetic Neuropathy Market Growth rate, Global Diabetic Neuropathy Market Makret Major Players, Global Diabetic Neuropathy Market Research Report, Global Diabetic Neuropathy Market Revenue, Global Diabetic Neuropathy Market Segmentation, Global Diabetic Neuropathy Market Share, Global Diabetic Neuropathy Market Size, India Diabetic Neuropathy Market Share, Lupin Diabetic Neuropathy Market Sales Growth, Middle East & Africa Diabetic Neuropathy Market, NeuroMetrix Diabetic Neuropathy Market, North America Diabetic Neuropathy Market, Pfizer Diabetic Neuropathy Market Competitors, U.S Diabetic Neuropathy Market Report